Clinical Trials Directory

Trials / Completed

CompletedNCT01512459

Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions

An Open Label, Balanced, Randomized, Two-treatment, Two-sequence Two-period, Single Dose Sprinkled on Apple Sauce, Crossover and Relative Bioavailability Study in Healthy Adult, Human Subjects Under Fed Conditions

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Dr. Reddy's Laboratories Limited · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The objective of this study was to compare the relative bioavailability of Venlafaxine MR Capsules 150 mg with Effexor XR Capsules 150 mg under Fed conditions in healthy adult human subjects.

Detailed description

An open labeL balanced, randomized, two-treatment. two-period, two-sequence, single dose,crossover, evaluation of relative bioavailability of Venlafaxine 150 mg (as the HCl salt)MR capsules of Dr. Reddy's comparing with that of Effexor XR (containing Venlafaxine 150 mg (as the HCl salt)capsules of wyeth Laboratories, Philadelphia, PA, USA in healthy human subjects under fed conditions.

Conditions

Interventions

TypeNameDescription
DRUGVenlafaxineVenlafaxine MR Capsules 150 mg

Timeline

Start date
2006-05-01
Primary completion
2006-05-01
Completion
2006-06-01
First posted
2012-01-19
Last updated
2012-01-19

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT01512459. Inclusion in this directory is not an endorsement.